Alpert Martin A, Ravenscraft Mark D
Department of Medicine, St John's Mercy Medical Center, St Louis, Missouri 63141, USA.
Am J Med Sci. 2003 Apr;325(4):228-36. doi: 10.1097/00000441-200304000-00009.
Pericardial involvement in end-stage renal disease (ESRD) is manifested most commonly as acute uremic or dialysis pericarditis and infrequently as chronic constrictive pericarditis. The causes of uremic and dialysis pericarditis remain uncertain. The clinical and laboratory manifestations of acute pericarditis, pericardial effusion, cardiac tamponade, and constrictive pericarditis in patients with chronic renal failure are similar to those observed in nonuremic patients with similar pericardial involvement, except that chest pain occurs less frequently in those with ESRD. Therapeutic interventions for acute uremic or dialysis pericarditis with or without pericardial effusion include intensive hemodialysis, pericardiocentesis (infrequently used), pericardiostomy with or without instillation of intrapericardial glucocorticoids, pericardial window, and pericardiectomy. Chronic constrictive pericarditis is treated with pericardiectomy.
终末期肾病(ESRD)的心包受累最常见表现为急性尿毒症性或透析相关性心包炎,很少表现为慢性缩窄性心包炎。尿毒症性和透析相关性心包炎的病因仍不明确。慢性肾衰竭患者急性心包炎、心包积液、心脏压塞和缩窄性心包炎的临床及实验室表现与非尿毒症性且有类似心包受累的患者相似,只是ESRD患者胸痛的发生率较低。对于有或无心包积液的急性尿毒症性或透析相关性心包炎,治疗干预措施包括强化血液透析、心包穿刺术(较少使用)、心包造口术(可加用或不加用心包内糖皮质激素灌注)、心包开窗术和心包切除术。慢性缩窄性心包炎采用心包切除术治疗。